Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

Background: Ketamine and esketamine offer a novel approach in the pharmacological treatment of major depressive disorder (MDD). This metaanalysis aimed to investigate the placebo response in double-blind, randomized controlled studies (RCTs) on patients with MDD receiving ketamine or esketamine....

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Matsingos, Alexandros, Wilhelm, Marcel, Noor, Laila, Yildiz, Cüneyt, Rief, Winfried, Hofman, Stefan G., Falkenberg, Irina, Kircher, Thilo
Materiálatiipa: Artihkal
Giella:eaŋgalasgiella
Almmustuhtton: Philipps-Universität Marburg 2024
Fáttát:
depression (MDD)
Medizin
placebo response
psychoactive medication
esketamine
treatment expectation
NMDA-receptor antagonist
ketamine
placebo
Medical sciences Medicine
Liŋkkat:PDF-ollesdeaksta
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Publikationen im Open Access gefördert durch die UB

Geahča maid